Pulmonary Thromboembolism
Abstract
Pulmonary thromboembolism (PE) continues to be an important challenge for clinical medicine, in some cases it can lead to rapid death, while in others it does not present with symptoms and can go asymptomatic, in addition, it is the third cause of death of cardiovascular origin. This disease is caused by the migration of a blood clot, mainly from the pelvic limbs, which lodges in a pulmonary artery causing its partial or complete obstruction. The purpose of this review is to describe the epidemiology, risk factors, and pathophysiology of PE and analyze the diagnosis and clinical manifestation of the disease, as well as its treatment and follow-up.
Downloads
References
Essien E-O, Rali P, Mathai SC. Pulmonary embolism. Med. Clin. North Am. 2019;103(3):549–564.
Heit JA. Epidemiology of venous thromboembolism. Nat. Rev. Cardiol. 2015;12(8):464–474.
Doherty S. Pulmonary embolism An update. Aust. Fam. Physician. 2017;46(11):816–820.
Laack TA, Goyal DG. Pulmonary embolism: an unsuspected killer. Emerg. Med. Clin. North Am. 2004;22(4):961–983.
Gob.mx. [citado el 25 de noviembre de 2021]. Disponible en: http://www.cenetec.salud.gob.mx/descargas/gpc/CatalogoMaestro/437_GPC_Enf_troboembolica_venosa/GER_Enfermedad_tromboembxlica_venosa.pdf
Majluf-Cruz A, Espinosa-Larrañaga F. Fisiopatología de la trombosis. Gac. Med. Mex. 2007;143(Suppl: 1):11-14.
Baloira Villar A, Ruiz Iturriaga LA. Tromboembolismo pulmonar. Arch. Bronconeumol. 2010;46:31–37.
Stevenson A, Davis S, Murch N. Pulmonary embolism in acute medicine: a case-based review incorporating latest guidelines in the COVID-19 era. Br. J. Hosp. Med. (Lond). 2020;81(6):1–12.
Chalikias GK, Tziakas DN, Stakos DA, Konstantinides SV. Management of acute pulmonary embolism: A contemporary, risktailored approach. Hellenic J. Cardiol. 2010; 51(5): 437-450.
Moser KM, LeMoine JR. Is embolic risk conditioned by location of deep venous thrombosis? Ann. Intern. Med. 1981;94(4 pt 1):439–444.
Geerts WH, Bergqvist D, Pineo GF, Heit JA, Samama CM, Lassen MR, et al. Prevention of venous thromboembolism: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest. 2008;133(6 Suppl):381S-453S.
Giordano NJ, Jansson PS, Young MN, Hagan KA, Kabrhel C. Epidemiology, pathophysiology, stratification, and natural history of pulmonary embolism. Tech. Vasc. Interv. Radiol. 2017;20(3):135–140.
Kostadima E, Zakynthinos E. Pulmonary embolism: pathophysiology, diagnosis, treatment. Hellenic J. Cardiol. 2007;48(2):94–107.
Schmidt GA. Pulmonic embolic disorders: Thrombus, Air and Fat. En: Hall JB, Schmidt GA, Wood LDH, editores. McGraw-Hill; 1992. p. 1476–1492.
Elliott CG. Pulmonary physiology during pulmonary embolism. Chest. 1992;101(4 Suppl):163S-171S.
Morici B. Diagnosis and management of acute pulmonary embolism. JAAPA. 2014; 27(4): 18-22.
Tarbox AK, Swaroop M. Pulmonary embolism. Int. J. Crit. Illn. Inj. Sci. 2013; 3(1): 69-72.
Zavaleta Martínez EO, Morales Blanhir JE. Tromboembolia pulmonar. Neum. Cir. Tórax. 2006; 65(1): 24-39.
Machado-Villarroel L, Dimakis-Ramírez DA. Enfoque diagnóstico de la tromboembolia pulmonar. Acta Méd. Gpo. Ángeles; 2017;15(1): 36-46.
Konstantinides SV, Meyer G, Becattini C, Bueno H, Geersing G-J, Harjola V-P, et al. ESC Guidelines for the diagnosis and management of acute pulmonary embolism developed in collaboration with the European Respiratory Society (ERS). Eur. Heart J. 2020;41(4):543–603.
Mercat A, Diehl JL, Meyer G, Teboul JL, Sors H. Hemodynamic effects of fluid loading in acute massive pulmonary embolism. Crit. Care Med. 1999;27(3):540–544.
Van Es N, Coppens M, Schulman S, Middeldorp S, Büller HR. Direct oral anticoagulants compared with vitamin K antagonists for acute venous thromboembolism: evidence from phase 3 trials. Blood. 2014;124(12):1968–1975.
Agnelli G, Buller HR, Cohen A, Curto M, Gallus AS, Johnson M, et al. Oral apixaban for the treatment of acute venous thromboembolism. N. Engl. J. Med. 2013;369(9):799–808.
Goldhaber SZ, Haire WD, Feldstein ML, Miller M, Toltzis R, Smith JL, et al. Alteplase versus heparin in acute pulmonary embolism: randomised trial assessing right-ventricular function and pulmonary perfusion. Lancet. 1993;341(8844):507–511.
Marti C, John G, Konstantinides S, Combescure C, Sanchez O, Lankeit M, et al. Systemic thrombolytic therapy for acute pulmonary embolism: a systematic review and meta-analysis. Eur. Heart J. 2015;36(10):605–614.
Abusibah H, Abdelaziz MM, Standen P, Bhatia P, Hamad MM. Ambulatory management of pulmonary embolism. Br. J. Hosp. Med. (Lond). 2018;79(1):18–25.
Tavoly M, Wik HS, Sirnes P-A, Jelsness-Jørgensen L-P, Ghanima JP, Klok FA, et al. The impact of post-pulmonary embolism syndrome and its possible determinants. Thromb. Res. 2018;171:84–91.
Copyright (c) 2022 Lucio Daniel Gómez Melo, Carlos A. González Pérez , Daniela León Bernal , Aylin S. Maldonado Velasco, José E. Ramírez Rodríguez , Mario I Ortiz
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
